Skip to main content
. 2014 Nov 1;29(9):395–402. doi: 10.1089/cbr.2014.1693

FIG. 2.

FIG. 2.

Effect of 125I-labeled 5-iodo-2′-deoxyuridine-chitosan drug loading nanoparticles (125I-UdR-CS-DLN) on HL-7702 and HepG2 cell survival. HL-7702 and HepG2 cells treated with different doses of 125I-UdR or 125I-UdR-CS-DLN for 24 and 48 hours, and the cell survival rate was assessed by the MTT assay (*p<0.05, **p<0.01).